BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23778703)

  • 1. Transporters in drug development and clinical pharmacology.
    Giacomini KM; Huang SM
    Clin Pharmacol Ther; 2013 Jul; 94(1):3-9. PubMed ID: 23778703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What do drug transporters really do?
    Nigam SK
    Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs.
    Torres-Vergara P; Rivera R; Escudero C; Penny J
    Adv Exp Med Biol; 2023; 1428():149-177. PubMed ID: 37466773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug transporters in drug efficacy and toxicity.
    DeGorter MK; Xia CQ; Yang JJ; Kim RB
    Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.
    Kis O; Robillard K; Chan GN; Bendayan R
    Trends Pharmacol Sci; 2010 Jan; 31(1):22-35. PubMed ID: 20004485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.
    Liu JJ; Lu J; McKeage MJ
    Curr Cancer Drug Targets; 2012 Oct; 12(8):962-86. PubMed ID: 22794121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
    Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
    Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of transporters in hepatic drug disposition].
    Gao CY; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2012 May; 47(5):565-72. PubMed ID: 22811997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and splicing of ABC and SLC transporters in the human blood-brain barrier measured with RNAseq.
    Suhy AM; Webb A; Papp AC; Geier EG; Sadee W
    Eur J Pharm Sci; 2017 May; 103():47-51. PubMed ID: 28188910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs.
    Rodrigues AC; Hirata MH; Hirata RD
    Pharmacogenomics; 2009 Jun; 10(6):1007-16. PubMed ID: 19530968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eUnaG: a new ligand-inducible fluorescent reporter to detect drug transporter activity in live cells.
    Yeh JT; Nam K; Yeh JT; Perrimon N
    Sci Rep; 2017 Feb; 7():41619. PubMed ID: 28176814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
    Liu X
    Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporters in human platelets: physiologic function and impact for pharmacotherapy.
    Jedlitschky G; Greinacher A; Kroemer HK
    Blood; 2012 Apr; 119(15):3394-402. PubMed ID: 22337717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Structure and Mechanism of Drug Transporters.
    Roberts AG
    Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
    Özvegy-Laczka C; Ungvári O; Bakos É
    Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological and clinical role of drug transporters at the intestinal barrier.
    Oostendorp RL; Beijnen JH; Schellens JH
    Cancer Treat Rev; 2009 Apr; 35(2):137-47. PubMed ID: 18986769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug-transporter interactions using in vitro and in vivo models.
    Xia CQ; Milton MN; Gan LS
    Curr Drug Metab; 2007 May; 8(4):341-63. PubMed ID: 17504223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.